Patent 7361770 was granted and assigned to Hetero Drugs Limited on April, 2008 by the United States Patent and Trademark Office.
Valsartan of formula (I) is prepared by hydrolysis of valsartan benzyl ester with an alkali metal hydroxide, washing with an organic solvent, acidifying with hydrochloric acid and isolating valsartan from the reaction mixture